Theolytics announces first patient dosed in the Octopod‑IP trial

28th April 2026 Uncategorised 0

US study marks company’s second clinical trial of ovarian cancer therapy

More: Theolytics announces first patient dosed in the Octopod‑IP trial
Source: News